Barrington Research keeps US Physical Therapy at Outperform, lifts target to $122
Barrington Research maintained its Outperform rating on US Physical Therapy and raised its price target from $110 to $122, according to TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to TradingView, analysts at Barrington Research kept their Outperform rating on US Physical Therapy shares and raised the price target from $110 to $122, a 10.9% increase. The new target implies 23.7% upside from the November 12 close of $98.60.
TradingView notes that the data comes from Benzinga and that the material is not personal investment advice.
why it matters
Price target changes from individual analysts are routine events for a single company's stock. For the broader market the signal is limited, but for investors in US Physical Therapy it shows that the brokerage has grown more optimistic about the shares. Each market participant makes its own decisions about the stock.
tags
instruments
sources
- Barrington Research maintains US Physical Therapy at Outperform, raises price target to $122 from $110 — TradingView, 13 November 2026 at 18:28 UTC
- US Physical Therapy Is Maintained at Outperform by Barrington Research — Dow Jones Newswires, 13 November 2026 at 18:38 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗